- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Patients With Multiple Sclerosis in United States
Total 1683 results
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom
-
Opexa Therapeutics, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BayerCompletedMultiple SclerosisUnited States, Canada
-
Imperial College LondonGlaxoSmithKlineWithdrawnHealthy Smokers | Healthy Non-smokers | Patients With Mild Asthma | Patints With COPD (GOLD II)United Kingdom
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
Brigham and Women's HospitalNovartisRecruitingRelapsing Multiple SclerosisUnited States
-
Georgia State UniversityMultiple Sclerosis Center of AtlantaActive, not recruitingRelapsing Multiple SclerosisUnited States
-
University of Texas Southwestern Medical CenterGenzyme, a Sanofi CompanyCompletedMultiple Sclerosis (MS)United States
-
University of LincolnNottingham University Hospitals NHS TrustCompletedDepression | Secondary-progressive Multiple SclerosisUnited Kingdom
-
Marquette UniversityUniversity of Wisconsin, MilwaukeeCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Northwestern UniversityTerminatedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Italy, Poland
-
Bristol-Myers SquibbTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedInpatients With Limited English ProficiencyUnited States
-
Atara BiotherapeuticsTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States, Australia, Canada
-
Tiziana Life Sciences LTDRecruitingSecondary Progressive Multiple SclerosisUnited States
-
George Washington UniversityJohns Hopkins UniversityCompletedPatients With Peripheral Intravenous Access LinesUnited States
-
Bristol-Myers SquibbCompleted
-
Englewood Hospital and Medical CenterWithdrawnInpatients With Normal Neurological FunctionUnited States
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
The University of Texas Health Science Center,...CompletedMultiple Sclerosis (MS)United States
-
NYU Langone HealthCompletedPediatric Multiple SclerosisUnited States
-
Massachusetts General HospitalCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
National Institute of Allergy and Infectious Diseases...Autoimmunity Centers of ExcellenceTerminatedMultiple Sclerosis (MS) - Relapsing-remittingUnited States
-
Johns Hopkins UniversityUnited States Department of DefenseRecruiting
-
University of Alabama at BirminghamRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
University of Illinois at Urbana-ChampaignUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
National Institute of Neurological Disorders and...TerminatedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
National Institute of Neurological Disorders and...CompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
University of Illinois at ChicagoTakeda Pharmaceuticals North America, Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
National Institute of Neurological Disorders and...CompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN); Repligen CorporationCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompleted
-
National Center for Complementary and Integrative...CompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
IMS HEALTH GmbH & Co. OHGEMD SeronoCompletedRelapsing-remitting Multiple SclerosisUnited States, Canada
-
MediciNovaNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaboratorsCompletedSafety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruiting
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple Sclerosis, Acute RelapsingUnited States
-
University of California, IrvineCompletedBarrett's Esophagus With or Without Dysplasia | Patients With Early Esophageal or Gastric Cancer | Patients With Intestinal Metaplasia of the StomachUnited States
-
University of Alabama at BirminghamCompletedMultiple Sclerosis (MS)United States
-
Providence Health & ServicesBristol-Myers Squibb; Milton S. Hershey Medical CenterWithdrawnMultiple Sclerosis | Relapsing Multiple SclerosisUnited States
-
EMD SeronoCompletedThe REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial (REGARD-PGx)Relapsing Multiple SclerosisUnited States
-
Immune Response BioPharma, Inc.croRecruitingMultiple Sclerosis | Secondary Progress Multiple SclerosisUnited States
-
University of Alabama at BirminghamNational Multiple Sclerosis SocietyNot yet recruitingMultiple Sclerosis, Relapsing-Remitting | Sexual DysfunctionUnited States
-
Berkovich, Regina MD, PhD Inc.Biogen; Cedars-Sinai Medical CenterRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Riley Bove, MDRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
University of California, San FranciscoCompletedMultiple Sclerosis, Relapsing-RemittingUnited States